Literature DB >> 2121789

Comparison of the outer membrane protein and lipopolysaccharide profiles of mucoid and nonmucoid Pseudomonas aeruginosa.

N M Kelly1, M H MacDonald, N Martin, T Nicas, R E Hancock.   

Abstract

Laboratory-derived mucoid variants of Pseudomonas aeruginosa were selected by plating the standard PAO1 laboratory strain with bacteriophage. These mucoid variants formed two distinct groups of strains on the basis of phage typing. The first group had the same phage-typing pattern as the parent PAO1 strain, while the second group had a distinctly different phage-typing pattern. One strain from each group was assessed along with the parent PAO1 strain for its outer membrane protein (OMP) and lipopolysaccharide (LPS) profiles by sodium dodecyl sulfate-gel electrophoresis followed by appropriate staining. The mucoid derivatives were found to differ from the parent PAO1 nonmucoid strain in having lost a high-molecular-weight LPS species. Furthermore, the reversion of the mucoid strains to the nonmucoid phenotype was accompanied by a return of the missing high-molecular-weight LPS species. No observable difference between the mucoid derivatives and the parent nonmucoid strain was noted in the OMP profiles. The opposite was found in the case of four isolates of mucoid P. aeruginosa from patients with cystic fibrosis. Two OMP bands (of approximately 55 and 25 kilodaltons) were present in the mucoid isolates but missing in their sister nonmucoid strains. In the case of the cystic fibrosis isolates, no difference in the LPS profiles within mucoid-nonmucoid pairs was noted.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2121789      PMCID: PMC268096          DOI: 10.1128/jcm.28.9.2017-2021.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  An outer membrane protein characteristic of mucoid strains of Pseudomonas aeruginosa.

Authors:  E Grabert; J Wingender; U K Winkler
Journal:  FEMS Microbiol Lett       Date:  1990-03-01       Impact factor: 2.742

2.  Transfer of a chromosomal locus responsible for mucoid colony morphology in Pseudomonas aeruginosa isolated from cystic fibrosis patients to P. aeruginosa PAO.

Authors:  J MacGeorge; V Korolik; A F Morgan; V Asche; B W Holloway
Journal:  J Med Microbiol       Date:  1986-06       Impact factor: 2.472

3.  Mucoid variation in Pseudomonas aeruginosa induced by the action of phage.

Authors:  D R Martin
Journal:  J Med Microbiol       Date:  1973-02       Impact factor: 2.472

4.  Determinants of the efficacy of tobramycin therapy against isogenic nonmucoid and mucoid derivatives of Pseudomonas aeruginosa PAO1 growing in peritoneal chambers in mice.

Authors:  N M Kelly; E G Rawling; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

5.  Outer membrane of Pseudomonas aeruginosa: heat- 2-mercaptoethanol-modifiable proteins.

Authors:  R E Hancock; A M Carey
Journal:  J Bacteriol       Date:  1979-12       Impact factor: 3.490

6.  Mucoid strains of Pseudomonas aeruginosa: the influence of culture medium on the stability of mucus production.

Authors:  J R Govan
Journal:  J Med Microbiol       Date:  1975-11       Impact factor: 2.472

7.  Dissociation in Pseudomonas aeruginosa.

Authors:  C H Zierdt; P J Schmidt
Journal:  J Bacteriol       Date:  1964-05       Impact factor: 3.490

8.  Production and characterization of the slime polysaccharide of Pseudomonas aeruginosa.

Authors:  L R Evans; A Linker
Journal:  J Bacteriol       Date:  1973-11       Impact factor: 3.490

9.  Surface characteristics of Pseudomonas aeruginosa grown in a chamber implant model in mice and rats.

Authors:  N M Kelly; A Bell; R E Hancock
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

10.  Partial purification and characterization of a polymannuronic acid depolymerase produced by a mucoid strain of Pseudomonas aeruginosa isolated from a patient with cystic fibrosis.

Authors:  W M Dunne; F L Buckmire
Journal:  Appl Environ Microbiol       Date:  1985-09       Impact factor: 4.792

View more
  7 in total

1.  Energetics and surface properties of Pseudomonas putida DOT-T1E in a two-phase fermentation system with 1-decanol as second phase.

Authors:  Grit Neumann; Sjef Cornelissen; Frank van Breukelen; Steffi Hunger; Holger Lippold; Norbert Loffhagen; Lukas Y Wick; Hermann J Heipieper
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

2.  Identification of Legionella species by lipopolysaccharide antigen pattern.

Authors:  D Jürgens; F J Fehrenbach
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

3.  Regulated proteolysis controls mucoid conversion in Pseudomonas aeruginosa.

Authors:  Dongru Qiu; Vonya M Eisinger; Donald W Rowen; Hongwei D Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

4.  Proteomic identification of OprL as a seromarker for initial diagnosis of Pseudomonas aeruginosa infection of patients with cystic fibrosis.

Authors:  Aparna R Rao; Anita Laxova; Philip M Farrell; Joseph T Barbieri
Journal:  J Clin Microbiol       Date:  2009-06-24       Impact factor: 5.948

5.  Comparisons of Two Proteomic Analyses of Non-Mucoid and Mucoid Pseudomonas aeruginosa Clinical Isolates from a Cystic Fibrosis Patient.

Authors:  Jayasimha Rao; F Heath Damron; Marek Basler; Antonio Digiandomenico; Nicholas E Sherman; Jay W Fox; John J Mekalanos; Joanna B Goldberg
Journal:  Front Microbiol       Date:  2011-08-01       Impact factor: 5.640

6.  Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium.

Authors:  Teresinha Leal; Gabriella Bergamini; François Huaux; Nadtha Panin; Sabrina Noel; Barbara Dhooghe; Jeremy B Haaf; Pierluigi Mauri; Sara Motta; Dario Di Silvestre; Paola Melotti; Claudio Sorio
Journal:  Front Immunol       Date:  2016-11-15       Impact factor: 7.561

7.  Remodeling of O Antigen in Mucoid Pseudomonas aeruginosa via Transcriptional Repression of wzz2.

Authors:  Ashley R Cross; Joanna B Goldberg
Journal:  mBio       Date:  2019-02-19       Impact factor: 7.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.